OPR - Delayed Quote • USD ABUS Sep 2024 3.000 call (ABUS240920C00003000) Follow 0.2800 -0.0200 (-6.67%) At close: April 26 at 12:19 PM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for ABUS240920C00003000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: ABUS Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna Is Arbutus Biopharma (NASDAQ:ABUS) In A Good Position To Deliver On Growth Plans? Arbutus to Participate in Two Upcoming Investor Conferences Arbutus Biopharma Corporation (NASDAQ:ABUS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report Analysts Just Made A Major Revision To Their Arbutus Biopharma Corporation (NASDAQ:ABUS) Revenue Forecasts Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Call Transcript Q4 2023 Arbutus Biopharma Corp Earnings Call Arbutus Biopharma (ABUS) Reports Q4 Loss, Misses Revenue Estimates Arbutus Biopharma Corp (ABUS) Reports Year-End Financial Results and Progress in Clinical Trials Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
